The hepatic apelin system: A new therapeutic target for liver disease†
Open accessAbstract
UNLABELLED: Apelin is a peptide that plays an important role in heart physiology and pathophysiology, inflammation, and angiogenesis. We evaluated whether the endogenous apelin system is involved in the pathogenesis of the hepatic remodeling and cardiovascular and renal complications occurring in advanced liver disease. The circulating levels of apelin, the messenger RNA (mRNA) and protein expression of apelin and apelin receptor, the immunohistological detection of apelin and apelin receptor, and the effects induced by the chronic administration of an apelin receptor antagonist on fibrosis and vessel density were evaluated in rats with cirrhosis and ascites and in control rats. The serum levels of apelin in patients with cirrhosis were also measured. Apelin levels were higher in rats with cirrhosis than in controls. Apelin mRNA showed a four-fold rise only in hepatic tissue, but not in the lung, heart, or kidney of rats with cirrhosis. These animals also showed hepatic apelin receptor mRNA levels 300 times higher than controls. Apelin was highly expressed by stellate cells, whereas apelin receptor was overexpressed in the hepatic parenchyma of animals with cirrhosis. Rats with cirrhosis treated with the apelin receptor antagonist showed diminished hepatic fibrosis and vessel density, improved cardiovascular performance, and renal function and lost ascites. Human patients also showed a marked increase in apelin levels. CONCLUSION: The selective hepatic activation of the apelin system, together with the drop in fibrosis and neoangiogenesis and the improvement in cardiovascular and excretory function resulting from apelin receptor blockade, points to the hepatic apelin system as a novel therapeutic target in liver disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Apelin has been implicated in disorders of glucose metabolism and in liver fibrosis.
“Apelin has been shown to be involved in glucose metabolism disorders and in hepatic fibrosis [52,53].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [53]
Cites
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · see citing works
Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor
Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M.-X., Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9489 · Cited by 1,684 · see citing works
Apelin, a Newly Identified Adipokine Up-Regulated by Insulin and Obesity
Boucher, J., Masri, B., Daviaud, D., Gesta, S., Guigné, C., Mazzucotelli, A., Castan-Laurell, I., Tack, I., Knibiehler, B., Carpéné, C., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1427 · Cited by 910 · see citing works
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
Tatemoto, K., Takayama, K., Zou, M.-X., Kumaki, I., Zhang, W. Y., KUMANO, K., & Fujimiya, M. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00236-1 · Cited by 640 · see citing works
Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility
Szokodi, I., Tavi, P., Földes, G., Voutilainen-Myllylä, S., Ilves, M., Tokola, H., Pikkarainen, S., Piuhola, J., Rysä, J., Tóth, M., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000033522.37861.69 · Cited by 625 · see citing works
Molecular properties of apelin: tissue distribution and receptor binding
Kawamata, Y., Habata, Y., Fukusumi, S., Hosoya, M., Fujii, R., Hinuma, S., Nishizawa, N., Kitada, C., Onda, H., Nishimura, O., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00143-9 · Cited by 521 · see citing works
Molecular and Functional Characteristics of APJ
Hosoya, M., Kawamata, Y., Fukusumi, S., Fujii, R., Habata, Y., Hinuma, S., Kitada, C., Honda, S., Kurokawa, T., Onda, H., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908417199 · Cited by 488 · see citing works
Ishida, J., Hashimoto, T., Hashimoto, Y., Nishiwaki, S., Iguchi, T., Harada, S., Sugaya, T., Matsuzaki, H., Yamamoto, R., Shiota, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404149200 · Cited by 411 · see citing works
Mota, N. D., Goazigo, A. R.-L., Messari, S. E., Chartrel, N., Roesch, D. M., Dujardin, C., Kordon, C., Vaudry, H., Moos, F., & Llorens‐Cortés, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403518101 · Cited by 364 · see citing works
Cox, C. M., D'Agostino, S. L., Miller, M. K., Heimark, R. L., & Krieg, P. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.04.452 · Cited by 328 · see citing works
Kleinz, M. J., & Davenport, A. P. (2003) · Regulatory Peptides · doi:10.1016/j.regpep.2003.11.002 · Cited by 291 · see citing works
Apelin Has In Vivo Inotropic Effects on Normal and Failing Hearts
Berry, M. F., Pirolli, T. J., Jayasankar, V., Burdick, J., Morine, K., Gardner, T. J., & Woo, Y.-P. J. (2004) · Circulation · doi:10.1161/01.cir.0000138382.57325.5c · Cited by 278 · see citing works
Li, L., Yang, G., Li, Q., Tang, Y., Yang, M., Yang, H., & Li, K. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-948309 · Cited by 268 · see citing works
Kidoya, H., Ueno, M., Yamada, Y., Mochizuki, N., Nakata, M., Yano, T., Fujii, R., & Takakura, N. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601982 · Cited by 265 · see citing works
Tugues, S., Fernández‐Varo, G., Muñoz, J., Ros, J., Arroyo, V., Rodés, J., Friedman, S. L., Carmeliet, P., Jiménez, W., & Morales‐Ruiz, M. (2007) · Hepatology · doi:10.1002/hep.21921 · Cited by 260 · see citing works
Self-citationModification of the Terminal Residue of Apelin-13 Antagonizes Its Hypotensive Action
Lee, D. K., Saldivia, V., Nguyen, T., Cheng, R., George, S. R., & O’Dowd, B. F. (2004) · Endocrinology · doi:10.1210/en.2004-0359 · Cited by 256 · see citing works
TNFα up‐regulates apelin expression in human and mouse adipose tissue
Daviaud, D., Boucher, J., Gesta, S., Dray, C., Guigné, C., Quilliot, D., Ayav, A., Ziegler, O., Carpéné, C., Saulnier‐Blache, J. S., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5243fje · Cited by 219 · see citing works
Apelin (65‐77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells
Masri, B., Morin, N., Cornu, M., Knibiehler, B., & Audigier, Y. (2004) · The FASEB Journal · doi:10.1096/fj.04-1930fje · Cited by 211 · see citing works
Doğru, T., Sönmez, A., Taşçı, İ., Bozoğlu, E., Yılmaz, M. İ., Genç, H., Erdem, G., Gök, M., Bingöl, N., Kılıç, S., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.031 · Cited by 201 · see citing works
Apelin (65–77) Activates Extracellular Signal-Regulated Kinases via a PTX-Sensitive G Protein
Masri, B., Lahlou, H., Mazarguil, H., Knibiehler, B., & Audigier, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6230 · Cited by 172 · see citing works
The G Protein-Coupled Receptor Agtrl1b Regulates Early Development of Myocardial Progenitors
Scott, I. C., Masri, B., D’Amico, L., Jin, S., Jungblut, B., Wehman, A. M., Baier, H., Audigier, Y., & Stainier, D. Y. R. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.01.012 · Cited by 171 · see citing works
Hypoxia inducible factor regulates the cardiac expression and secretion of apelin
Ronkainen, V., Ronkainen, J. J., Hänninen, S. L., Leskinen, H. K., Ruas, J. L., Pereira, T., Poellinger, L., Vuolteenaho, O. J., & Tavi, P. (2007) · The FASEB Journal · doi:10.1096/fj.06-7294com · Cited by 168 · see citing works
Low Plasma Apelin Levels in Newly Diagnosed Type 2 Diabetes Mellitus
Erdem, G., Doğru, T., Taşçı, İ., Sönmez, A., & Tapan, S. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-1004564 · Cited by 127 · see citing works
Endocannabinoids and liver disease† ‡
Jiménez, W. (2005) · Hepatology · doi:10.1002/hep.20714 · Cited by 74 · see citing works
Self-citationNitric Oxide Synthase 3-Dependent Vascular Remodeling and Circulatory Dysfunction in Cirrhosis
Fernández‐Varo, G., Ros, J., Morales‐Ruiz, M., Cejudo–Martín, P., Arroyo, V., Solé, M., Rivera, F., Rodés, J., & Jiménez, W. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64331-3 · Cited by 74 · see citing works
Self-citationPlasma Apelin is Lower in Patients with Elevated LDL-Cholesterol
Taşçı, İ., Doğru, T., Naharcı, M. İ., Erdem, G., Yılmaz, M. İ., Sönmez, A., Bingöl, N., Kilic, S., Bingöl, S., & Erikci, S. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-971067 · Cited by 66 · see citing works
LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia
Taşçı, İ., Erdem, G., Özgür, G., Tapan, S., Doğru, T., Genç, H., Açıkel, C., Özgürtaş, T., & Sönmez, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.030 · Cited by 54 · see citing works
Horiuchi, Y., Fujii, T., Kamimura, Y., & Kawashima, K. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.08.029 · Cited by 49 · see citing works
Sung, S., Chuang, S., Sheu, W. H., Lee, W., Chou, P., & Chen, C.-H. (2008) · Hypertension Research · doi:10.1291/hypres.31.633 · Cited by 23 · see citing works
Ros, J., Fernández‐Varo, G., Muñoz, J., Arroyo, V., Rodés, J., Gunnet, J. W., Demarest, K. T., & Jiménez, W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706375 · Cited by 14 · see citing works
Self-citationExperimental Models of Cirrhosis and Ascites
Clària, J., & Jiménez, W. (2005) · doi:10.1002/9780470987476.ch17 · Cited by 11 · see citing works
Self-citationNitric Oxide and Systemic and Renal Hemodynamic Disturbances in Cirrhosis
Morales‐Ruiz, M., & Jiménez, W. (2005) · doi:10.1002/9780470987476.ch8 · Cited by 5 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Adipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 470 · see citing works
Adipokines in nonalcoholic fatty liver disease
Pοlyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.11.006 · Cited by 359 · see citing works
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
O’Carroll, A., Lolait, S. J., Harris, L. E., & Pope, G. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0227 · Cited by 339 · see citing works
Adipokines – removing road blocks to obesity and diabetes therapy
Blüher, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.005 · Cited by 273 · see citing works
Chakaroun, R., Raschpichler, M., Klöting, N., Oberbach, A., Flehmig, G., Kern, M., Schön, M. R., Shang, E., Lohmann, T., Dreßler, M., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.10.008 · Cited by 234 · see citing works
Clinical Relevance of Adipokines
Blüher, M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.5.317 · Cited by 202 · see citing works
Pitkin, S. L., Maguire, J. J., Bonner, T. I., & Davenport, A. P. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002949 · Cited by 198 · see citing works
Cellular and molecular mechanisms in liver fibrogenesis
Novo, E., Cannito, S., Paternostro, C., Bocca, C., Miglietta, A., & Parola, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.02.015 · Cited by 190 · see citing works
Lee, M.-W., Lee, M., & Oh, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060854 · Cited by 180 · see citing works
Adipokines as Drug Targets in Diabetes and Underlying Disturbances
Andrade‐Oliveira, V., Câmara, N. O. S., & Moraes‐Vieira, P. M. (2015) · Journal of Diabetes Research · doi:10.1155/2015/681612 · Cited by 166 · see citing works
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170042 · Cited by 187 · see citing works
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 154 · see citing works
Angiogenesis and liver fibrosis
Elpek, G. Ö. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.377 · Cited by 157 · see citing works
Angiogenesis and Fibrogenesis in Chronic Liver Diseases
Bocca, C., Novo, E., Miglietta, A., & Parola, M. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.06.011 · Cited by 153 · see citing works
Monocyte-endothelial cell interactions in vascular and tissue remodeling
Medrano-Bosch, M., Simón-Codina, B., Jiménez, W., Edelman, E. R., & Melgar‐Lesmes, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196033 · Cited by 157 · see citing works
Self-citationApelin, a promising target for type 2 diabetes treatment?
Castan‐Laurell, I., Dray, C., Knauf, C., Kunduzova, O., & Valet, P. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.02.005 · Cited by 150 · see citing works
Zhu, S., Sun, F., Li, W., Cao, Y., Wang, C., Wang, Y., Dong, L., Zhang, R., Zhang, S., Wang, H., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0799-0 · Cited by 140 · see citing works
Adipocytokines and hepatic fibrosis
Saxena, N. K., & Anania, F. A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.01.002 · Cited by 136 · see citing works
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice #
Österreicher, C. H., Taura, K., Minicis, S. D., Seki, E., Penz-Österreicher, M., Kodama, Y., Kluwe, J., Schuster, M., Oudit, G. Y., Penninger, J. M., et al. (2009) · Hepatology · doi:10.1002/hep.23104 · Cited by 132 · see citing works
Krist, J., Wieder, K., Klöting, N., Oberbach, A., Kralisch, S., Wiesner, T., Schön, M. R., Gärtner, D., Dietrich, A., Shang, E., et al. (2013) · Obesity Facts · doi:10.1159/000348667 · Cited by 124 · see citing works
Read, C., Nyimanu, D., Williams, T., Huggins, D. J., Šulentić, P., Macrae, R. G. C., Yang, P. B., Glen, R. C., Maguire, J. J., & Davenport, A. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017533 · Cited by 124 · see citing works
Apelin Attenuates Hyperoxic Lung and Heart Injury in Neonatal Rats
de Visser, Y. P., Walther, F. J., Laghmani, E. H., van der Laarse, A., & Wagenaar, G. T. M. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1361oc · Cited by 97 · see citing works
Apelinergic System Structure and Function
Shin, K., Kenward, C., & Rainey, J. K. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170028 · Cited by 95 · see citing works
Rai, R., Ghosh, A. K., Eren, M., Mackie, A. R., Levine, D. C., Kim, S., Cedernaes, J., Ramirez, V., Procissi, D., Smith, L. H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.057 · Cited by 90 · see citing works
Taveau, C., Chollet, C., Waeckel, L., Desposito, D., Bichet, D. G., Arthus, M.-F., Magnan, C., Philippe, E., Paradis, V., Foufelle, F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3496-9 · Cited by 86 · see citing works
Apelin/APJ system: A novel promising therapy target for pathological angiogenesis
Wu, L., Chen, L., & Li, L. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.12.023 · Cited by 86 · see citing works
Apelin/APJ system in inflammation
Wang, X., Zhang, L., Li, P., Zheng, Y., Yang, Y., & Ji, S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108822 · Cited by 83 · see citing works
Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma
Li, H. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1842732 · Cited by 76 · see citing works
Tiani, C., García‐Pras, E., Mejías, M., Gottardi, A. D., Berzigotti, A., Bosch, J., & Fernández, M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.019 · Cited by 77 · see citing works
Melgar‐Lesmes, P., Pauta, M., Reichenbach, V., Casals, G., Ros, J., Bataller, R. A., Morales‐Ruiz, M., & Jiménez, W. (2011) · Gut · doi:10.1136/gut.2010.234690 · Cited by 69 · see citing works
Self-citationApelin and APJ, a novel critical factor and therapeutic target for atherosclerosis
Lv, D., Li, H., & Chen, L. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt040 · Cited by 68 · see citing works
Reichenbach, V., Ros, J., Fernández‐Varo, G., Casals, G., Melgar‐Lesmes, P., Campos, T., Makriyannis, A., Morales‐Ruiz, M., & Jiménez, W. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188078 · Cited by 64 · see citing works
Self-citationApelin Mediates the Induction of Profibrogenic Genes in Human Hepatic Stellate Cells
Melgar‐Lesmes, P., Casals, G., Pauta, M., Ros, J., Reichenbach, V., Bataller, R. A., Morales‐Ruiz, M., & Jiménez, W. (2010) · Endocrinology · doi:10.1210/en.2010-0754 · Cited by 63 · see citing works
Self-citationInhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth
Hall, C. M., Ehrlich, L., Venter, J. K., O’Brien, A., White, T. K., Zhou, T., Dang, T., Meng, F., Invernizzi, P., Bernuzzi, F., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.025 · Cited by 63 · see citing works
Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C
EL-Mesallamy, H. O., Hamdy, N. Μ., Rizk, H. H., & El‐Zayadi, A. (2011) · Mediators of Inflammation · doi:10.1155/2011/703031 · Cited by 60 · see citing works
The apelin–APJ axis: A novel potential therapeutic target for organ fibrosis
Huang, S., Chen, L., Lu, L., & Li, L. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.025 · Cited by 54 · see citing works
The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
Méndez‐Sánchez, N., Valencia-Rodríguez, A., Coronel-Castillo, C. E., Vera-Barajas, A., Contreras-Carmona, J., Ponciano‐Rodríguez, G., & Zamora‐Valdés, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.184 · Cited by 54 · see citing works
Apelin/APJ system: A key therapeutic target for liver disease
Lv, S., Cui, B., Chen, W., & Wang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22841 · Cited by 52 · see citing works
The protective effect of apelin on ischemia/reperfusion injury
Yang, Y., Lv, S., Lyu, S.-K., Wu, D., & Chen, Q. (2014) · Peptides · doi:10.1016/j.peptides.2014.11.001 · Cited by 52 · see citing works
The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis
Wang, L., Diao, Z.-L., Zhang, D., Zheng, J., Zhang, Q., Ding, J., & Liu, W. (2014) · Amino Acids · doi:10.1007/s00726-014-1826-8 · Cited by 51 · see citing works
The apelinergic system: a promising therapeutic target
Falcão‐Pires, I., Ladeiras‐Lopes, R., & Leite-Moreira, A. F. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003752743 · Cited by 50 · see citing works
Function and regulation of apelin/APJ system in digestive physiology and pathology
Huang, Z., Luo, X., Liu, M., & Chen, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27720 · Cited by 51 · see citing works
The Adipokines in Cancer Cachexia
Mannelli, M., Gamberi, T., Magherini, F., & Fiaschi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144860 · Cited by 50 · see citing works
Kalafateli, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3020 · Cited by 50 · see citing works
Blockade of the Renin-Angiotensin System Ameliorates Apelin Production in 3T3-L1 Adipocytes
Hung, W., Hsieh, T., Lin, T. H., Chou, P.-C., Hsiao, P., Lin, K., & Shin, S. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6274-4 · Cited by 48 · see citing works
Lower serum apelin levels in women with polycystic ovary syndrome
Chang, C., Tsai, Y.-C., Lee, C., Chan, T., Wang, S., & Su, J.-H. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.044 · Cited by 46 · see citing works
Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells
Wang, Y., Song, J., Bian, H., Bo, J., Lv, S., Pan, W., & Lv, X. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03581-0 · Cited by 45 · see citing works
Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
Melgar‐Lesmes, P., Perramón, M., & Jiménez, W. (2019) · Cells · doi:10.3390/cells8111311 · Cited by 45 · see citing works
Self-citationThe Role of the Apelin/APJ System in the Regulation of Liver Disease
Lv, X., Kong, J., Chen, W., & Wang, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00221 · Cited by 42 · see citing works
Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.
Cannito, S., Paternostro, C., Busletta, C., Bocca, C., Colombatto, S., Miglietta, A., Novo, E., & Parola, M. (2014) · PubMed · doi:10.14670/hh-29.33 · Cited by 41 · see citing works
Chen, L., Zhou, T., White, T. K., O’Brien, A., Chakraborty, S., Liangpunsakul, S., Yang, Z., Kennedy, L. L., Saxena, R., Wu, C., et al. (2020) · Hepatology · doi:10.1002/hep.31545 · Cited by 41 · see citing works
Plasma apelin levels in subjects with nonalcoholic fatty liver disease
Erçin, C. N., Doğru, T., Tapan, S., Kara, M., Haymana, C., Karadurmuş, N., Karslıoğlu, Y., & Açıkel, C. (2010) · Metabolism · doi:10.1016/j.metabol.2009.10.019 · Cited by 40 · see citing works
Lim, Y. L., Choi, E. H., Jang, Y. O., Cho, Y. Z., Kang, Y. S., Baik, S. K., Kwon, S. O., & Kim, M. Y. (2015) · Gut and Liver · doi:10.5009/gnl14345 · Cited by 38 · see citing works
Son, J. S., Kim, H., Son, Y., Lee, H., Chae, S. A., Seong, J. K., & Song, W. J. (2017) · Muscle & Nerve · doi:10.1002/mus.25596 · Cited by 38 · see citing works
Headgroup-Dependent Membrane Catalysis of Apelin−Receptor Interactions Is Likely
Langelaan, D. N., & Rainey, J. K. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp904562q · Cited by 37 · see citing works
Angiogenesis and portal-systemic collaterals in portal hypertension
Gana, J. C., Serrano, C. A., & Ling, S. C. (2016) · Annals of Hepatology · doi:10.5604/16652681.1198799 · Cited by 35 · see citing works
Sağıroğlu, T., Torun, N., Yağcı, M. A., Yalta, T. D., Sağıroğlu, G., & Oğuz, S. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.499 · Cited by 35 · see citing works
Yokomori, H., Oda, M., Yoshimura, K., Machida, S., Kaneko, F., & Hibi∥, T. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0296-3 · Cited by 33 · see citing works
Huang, J., Kang, S., Park, S.-J., & Im, D. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.08.003 · Cited by 31 · see citing works
Modulation of Liver Fibrosis by Adipokines
Marra, F., Navari, N., Vivoli, E., Galastri, S., & Provenzano, A. (2011) · Digestive Diseases · doi:10.1159/000329799 · Cited by 30 · see citing works
Bertrand, C., Pradère, J., Geoffre, N., Deleruyelle, S., Masri, B., Personnaz, J., Gonidec, S. L., Batut, A., Louche, K., Moro, C., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1536-1 · Cited by 29 · see citing works
Serum Apelin and Obesity-Related Complications in Egyptian Children
Wakeel, M. A. E., El-Kassas, G. M., Kamhawy, A. H., Galal, E. M., Nassar, M. S., Hammad, E. M., & El-Zayat, S. R. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.312 · Cited by 28 · see citing works
Involvement of the apelin receptor APJ in Fas‐induced liver injury
Yasuzaki, H., Yoshida, S., Hashimoto, T., Shibata, W., Inamori, M., Toya, Y., Tamura, K., Maeda, S., & Umemura, S. (2012) · Liver International · doi:10.1111/liv.12006 · Cited by 27 · see citing works
Importance of adipokines in glucose homeostasis
Blüher, M. (2013) · Diabetes Management · doi:10.2217/dmt.13.35 · Cited by 26 · see citing works
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00046.x · Cited by 23 · see citing works
Abd-Elbaky, A. E., Abo–Elmatty, D. M., Mesbah, N. M., & Ibrahim, S. M. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0416-y · Cited by 23 · see citing works
Chen, W., Oue, T., Ueno, T., Uehara, S., Usui, N., & Fukuzawa, M. (2012) · Pediatric Surgery International · doi:10.1007/s00383-012-3210-7 · Cited by 23 · see citing works
Babaei, P., Dastras, A., Tehrani, B. S., & Roudbaneh, S. P. (2017) · Journal of Menopausal Medicine · doi:10.6118/jmm.2017.23.3.182 · Cited by 23 · see citing works
Son, J. S., Chae, S. A., Park, B. I., Du, M., & Song, W. (2019) · Endocrinología, Diabetes y Nutrición · doi:10.1016/j.endinu.2018.12.005 · Cited by 21 · see citing works
Fernández‐Varo, G., Oró, D., Cable, E. E., Reichenbach, V., Carvajal, S., de la Presa, B. G., Wiśniewski, K., Ginès, P., Harris, G., & Jiménez, W. (2015) · Hepatology · doi:10.1002/hep.28250 · Cited by 20 · see citing works
Self-citationYokomori, H., Oda, M., Yoshimura, K., & Hibi∥, T. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00945.x · Cited by 19 · see citing works
Mechanism of KLF4 Protection against Acute Liver Injury via Inhibition of Apelin Signaling
Ji, W., Shi, H., Shen, H., Kong, J., Song, J.-Y., Bian, H.-Y., & Lv, X.-R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6140360 · Cited by 15 · see citing works
Effect of Leptin and Apelin Preconditioning on Hepatic Ischemia Reperfusion Injury in Rats
Sağıroğlu, T., Aksoy, M. B., Sağıroğlu, G., Tozkır, H., Oğuz, S., Yalta, T. D., Yağcı, M. A., & Sezer, A. (2012) · Indian Journal of Surgery · doi:10.1007/s12262-012-0676-4 · Cited by 19 · see citing works
Farid, R. M., Abu-Zeid, R. M., & El-Tawil, A. (2014) · PubMed Central · Cited by 19 · see citing works
Ibrahim, R. S., El-Mezayen, N. S., & El‐Banna, A. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15958-1 · Cited by 18 · see citing works
Apelinergic System Structure and Function
Shin, K., Kenward, C., & Rainey, J. K. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00012.x · Cited by 17 · see citing works
Do adipokines link obesity to its related metabolic and cardiovascular diseases?
Blüher, M. (2010) · Clinical Lipidology · doi:10.2217/clp.09.86 · Cited by 17 · see citing works
Pathophysiology of Portal Hypertension
Morales‐Ruiz, M., Rodríguez‐Vita, J., Ribera, J., & Jiménez, W. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_144 · Cited by 17 · see citing works
Self-citationJia, H., Aw, W., Saito, K., Hanate, M., Hasebe, Y., & Kato, H. (2014) · Scientific Reports · doi:10.1038/srep07473 · Cited by 17 · see citing works
Antiangiogenic therapies in portal hypertension: A breakthrough in hepatology
Rosmorduc, O. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.05.007 · Cited by 17 · see citing works
Ilaghi, M., Soltanizadeh, A., Amiri, S., Kohlmeier, K. A., & Shabani, M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175353 · Cited by 15 · see citing works
Owen, N. E., Nyimanu, D., Kuc, R. E., Upton, P. D., Morrell, N. W., Alexander, G., Maguire, J. J., & Davenport, A. P. (2020) · Peptides · doi:10.1016/j.peptides.2020.170440 · Cited by 14 · see citing works
Predictive and Diagnostic Value of Serum Adipokines in Pregnant Women with Intrahepatic Cholestasis
Yurtçu, N., Çalışkan, C. S., GÜVEY, H., Çelik, S., Hatırnaz, Ş., & Tinelli, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042254 · Cited by 14 · see citing works
Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy.
Lü, Q., Ma, Y., Xu, Y.-S., & Jiang, Y. (2014) · PubMed Central · Cited by 13 · see citing works
Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients
Małyszko, J., Koźmiński, P., Małyszko, J. S., & Myśliwiec, M. (2009) · International Urology and Nephrology · doi:10.1007/s11255-009-9667-1 · Cited by 11 · see citing works
Cytokine Production and Signaling in Stellate Cells
Marra, F., & Caligiuri, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00005-1 · Cited by 11 · see citing works
Bayraktar, B., Tekçe, E., Aksakal, V., Gül, M., Takma, Ç., Bayraktar, S., Bayraktar, F. G., & Eser, G. (2020) · Italian Journal of Animal Science · doi:10.1080/1828051x.2020.1778548 · Cited by 10 · see citing works
Lv, S., Zhang, X., Zhou, Y., Feng, Y., Yang, Y., & Wang, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01335 · Cited by 10 · see citing works
Emam, M. N., & Gheit, R. E. A. E. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.11.003 · Cited by 8 · see citing works
Adipokines in Nonalcoholic Fatty Liver Disease
Baranova, A. V., Birerdinc, A., & Younossi, Z. M. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_17 · Cited by 8 · see citing works
Aktan, A. K., & Kutlay, Ö. (2023) · Protein and Peptide Letters · doi:10.2174/0929866530666230824142516 · Cited by 7 · see citing works
Huang, Y. G., Zhang, S., Weng, J., Huang, D., & Gu, W. (2022) · Open Medicine · doi:10.1515/med-2022-0481 · Cited by 6 · see citing works
Pathophysiology of Portal Hypertension
Morales‐Ruiz, M., Rodríguez‐Vita, J., Ribera, J., & Jiménez, W. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_144-1 · Cited by 6 · see citing works
Self-citationDoğru, T., Erçin, C. N., Erdem, G., Kılcıler, G., & Tapan, S. (2008) · Hepatology · doi:10.1002/hep.22688 · Cited by 5 · see citing works
Apelin C-Terminal Fragments: Biological Properties and Therapeutic Potential
Pisarenko, O. I., & Studneva, I. M. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923110160 · Cited by 4 · see citing works
Ibrahim, S. M., & Bastawy, A. A. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666191210122851 · Cited by 4 · see citing works
Balta, Ş., Demırkol, S., Celık, T., Ünlü, M., Küçük, U., & Arslan, Z. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12120 · Cited by 4 · see citing works
Karampatsou, S., Paltoglou, G., Genitsaridi, S. M., Kassari, P., & Charmandari, E. (2024) · Nutrients · doi:10.3390/nu16213646 · Cited by 3 · see citing works
Slotki, I. N., & Skorecki, K. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10014-4 · Cited by 3 · see citing works
Kälin, S., & Kälin, R. E. (2016) · Energy balance and cancer · doi:10.1007/978-3-319-41677-9_7 · Cited by 3 · see citing works
- Authors
- Principe, A., Melgar‐Lesmes, P., Fernández‐Varo, G., del Arbol, L. R., Ros, J., Morales‐Ruiz, M., Bernardi, M., Arroyo, V., & Jiménez, W.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Corresponding author
- Jiménez, Wladimiro
- ORCID
- Venue
- Hepatology
- Published
- 2008-10
- Volume
- 48
- Issue
- 4
- Pages
- 1193-1201
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1978999795
- Cited by
- 127
- References
- 32
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 7 · 2020: 11 · 2019: 9 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 17 · 2014: 10 · 2013: 7 · 2012: 9
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Apelin-related biomedical research
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- apelin, apelin receptor, liver cirrhosis, liver fibrosis, ascites, hepatic stellate cells, neoangiogenesis, cardiovascular complications, renal function, advanced liver disease, therapeutic target
- MeSH terms
- Apelin, Adult, Animals, Blood Pressure, Carbon Tetrachloride, Carrier Proteins, Disease Models, Animal, Female, Humans, Liver, Liver Cirrhosis, Male, Middle Aged, Renin-Angiotensin System, RNA, Messenger, Sympathetic Nervous System, Vascular Resistance, Case-Control Studies, Rats, Wistar, Intercellular Signaling Peptides and Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
